The results of this study demonstrate that the Omnipod 5 AID System may reduce the emotional and behavioral burdens of T1D, heighten the user’s confidence in avoiding or addressing hypoglycemia-related problems, and increase their satisfaction with insulin delivery and diabetes management, while also assuring perceptions of relative ease-of-use. The gene discussed is INS; the disease is type 1 diabetes mellitus.